Notice Number: NOT-OD-05-060
Key Dates
Release Date: August 4, 2005
Contract Proposal Receipt Date: November 4, 2005
Issued by
National Institutes of Health (NIH), (http://www.nih.gov/)
Centers for Disease Control and Prevention (CDC), (http://www.cdc.gov/)
Innovative technologies and methodologies fuel progress in biomedical and behavioral research and represent an increasingly important area of the economy. The Small Business Innovation Research (SBIR) program provides support for research and development (R&D) of new or improved technologies and methodologies that have the potential to succeed as commercial products.
The purpose of this notice is to (1) announce the issuance of the SOLICITATION OF THE PUBLIC HEALTH SERVICE FOR SMALL BUSINESS INNOVATION RESEARCH CONTRACT PROPOSALS (PHS 2006-1) with a due date of NOVEMBER 4, 2005 for receipt of SBIR CONTRACT proposals; and (2) inform the public about the opportunities that the SBIR program offers to small business concerns as well as to scientists at research institutions. The SBIR legislation requires the Public Health Service (PHS), Department of Health and Human Services, and certain other federal agencies to reserve 2.5 percent of their extramural research or R&D budgets for an SBIR program. The PHS SBIR set-aside requirement for FY 2004 is $571 million.
The offeror organization must be a small business concern as defined by the Small Business Administration and described in the Solicitation, and the PRIMARY EMPLOYMENT of the principal investigator MUST be with the small business concern at the time of award and during the conduct of the proposed project. In accord with the intent of the SBIR program to increase private sector commercialization of innovations derived from federal R&D, scientists at research institutions can play an important role in an SBIR project by serving as consultants and/or subcontractors to the small business concern. Generally, one-third of the Phase I budget may be spent on consultant and/or subcontractual costs, and, generally, one-half of the Phase II budget may be spent on such costs. In this manner, a small business concern with limited expertise and/or research facilities may benefit from teaming with a Scientist(s)at a research institution; for the scientist(s)at a research institution, this team effort provides support for R&D not otherwise obtained.
The SBIR program consists of the following three phases:
PHASE I: The objective of this phase is to determine the scientific and technical merit and feasibility and potential for commercialization of the proposed research or R&D efforts and the quality of performance of the small business concern, before consideration of further federal support in Phase II. Generally, Phase I SBIR awards do not exceed $100,000 for direct costs, Facilities and Administrative (F&A) costs, and negotiated fixed fee for a period generally not to exceed six months.
PHASE II: The objective of this phase is to continue the research or R&D efforts initiated in Phase I. Funding shall be based on the results of Phase I and the scientific and technical merit and commercial potential of the Phase II proposal. Only Phase I contractors are eligible to apply for Phase II funding, and Phase II proposals may be submitted upon the request of the Contracting Officer ONLY. (However, see "Fast-Track" Initiative below.) Generally, Phase II awards do not exceed $750,000 for direct costs, F&A costs, and negotiated fixed fee for a period generally not to exceed two years. That is, generally, a two-year Phase II project does not cost more than $750,000 for that project. Only one Phase II award may be made for any SBIR project.
PHASE III: The objective of this phase is for the small business concern to pursue, with non-SBIR funds, the commercialization of the results of the research or R&D funded in Phases I and II.
"FAST-TRACK" INITIATIVE: (Applicable only to proposals submitted to the National Institutes of Health [NIH] and only if an awarding component indicates it is accepting Fast Track proposals for a particular topic.)
The Fast-Track initiative is an opportunity for small business concerns to submit both a Phase I and Phase II proposal for concurrent peer review. This initiative also has the potential to minimize any funding gap between Phase I and Phase II. Proposals must be prepared in accordance with Phase I and Phase II proposal preparation instructions.
Following are the research topics contained in the SOLICITATION OF THE PUBLIC HEALTH SERVICE FOR SMALL BUSINESS INNOVATION RESEARCH CONTRACT PROPOSALS (PHS 2006-1) for the contract proposal RECEIPT DATE of NOVEMBER 4, 2005:
National Institutes of Health
National Cancer Institute (NCI)
National Institute on Drug Abuse (NIDA)
National Institute of Mental Health (NIMH)
National Heart, Lung, and Blood Institute (NHLBI)
Centers for Disease Control and Prevention (CDC)
National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP)
National Center for HIV, STD and TB Prevention (NCHSTP)
National Immunization Program (NIP)
Inquiries
Eligibility requirements, definitions, submission procedures, review considerations, contract proposal forms and instructions, and other pertinent information, including the "Fast-Track" Initiative, are contained in the SOLICITATION OF THE PUBLIC HEALTH SERVICE FOR SMALL BUSINESS INNOVATION RESEARCH CONTRACT PROPOSALS (PHS 2005-1) for the proposal receipt date of November 4, 2005. The PHS SBIR Contract Solicitation PHS 2006-1, including proposal forms, is available electronically through the National Institutes of Health's "Small Business Funding Opportunities" home page at http://grants.nih.gov/grants/funding/sbir.htm. See SBIR Phase I Contract Solicitation PHS 2006-1 (PDF [http://grants.nih.gov/grants/funding/SBIRContract/PHS2006-1.pdf] or MS Word [http://grants.nih.gov/grants/funding/SBIRContract/PHS2006-1.doc]). Be sure to use the appropriate CONTRACT PROPOSAL forms as they differ from the PHS 398 GRANT application forms.
Note: The SBIR Phase I Contract Solicitation will only be available via electronic means. Potential offerors are encouraged to check the NIH SBIR/STTR home page for updates on the program. Any updates or corrections to the solicitation will be posted there.
Contracting Officers
Any small business concern that intends to submit an SBIR contract proposal under this Solicitation should provide the appropriate contracting officer(s) with early, written notice of its intent, giving its name, address, telephone, and topic number(s). If a topic is modified or canceled before this Solicitation closes, only those companies that have expressed such intent will be notified.
National Institutes of Health (NIH)
National Cancer Institute (NCI)
Ms. Mary Landi-O Leary
Phone: (301) 435-3807
Fax: (301) 480-0309
Email: ml186r@nih.gov
National Institute on Drug Abuse (NIDA)
Ms. Nancy A. Hurd
Phone: (301) 443-6677
Fax: (301) 443-7595
Email: nhurd@nida.nih.gov
National Institute of Mental Health (NIMH)
Mr. David Eskenazi
Phone: (301) 443-2696
Fax: (301) 443-0501
Email: de5d@nih.gov
National Heart, Lung, and Blood Institute (NHLBI)
Mr. John Taylor
Phone: (301) 435-0327
Fax: (301) 480-3338
E-mail: taylorjc@nhlbi.nih.gov
Centers for Disease Control and Prevention
National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP)
National Center for HIV, STD, and TB Prevention (NCHSTP)
National Immunization Program (NIP)
Mr. Curt Bryant
Phone: (770) 488-2806
Fax: (770) 488-2828
Email: ckb9@cdc.gov
Those interested in the PHS SBIR/STTR GRANT program may access electronically (http://grants.nih.gov/grants/funding/sbir.htm) the OMNIBUS SOLICITATION OF THE PUBLIC HEALTH SERVICE FOR SMALL BUSINESS INNOVATION RESEARCH (SBIR) and SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) GRANT APPLICATIONS (PHS 2005-2). There is one GRANT APPLICATION receipt date (December 1, 2005) remaining for calendar year 2005.
To better understand the differences between grants and contracts, see http://grants.nih.gov/grants/funding/contracts_vs_grants.htm.
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
| ||||||
Department of Health and Human Services (HHS) |
||||||
NIH... Turning Discovery Into Health® |